SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS

新型生物活性天然产物的合成

基本信息

  • 批准号:
    2684735
  • 负责人:
  • 金额:
    $ 19.12万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1982
  • 资助国家:
    美国
  • 起止时间:
    1982-09-15 至 1999-12-31
  • 项目状态:
    已结题

项目摘要

The studies to be conducted under this grant fall in four major areas: 1) complete work on the total synthesis of the hypoglycemic agent Saudin (1); test 1 and its precursors to identify the pharmacophore, and determine if possible the mechanism by which the hypoglycemic effects are elicited (in collaboration with Sandoz Research Institute); prepare appropriate analogues as warranted by the preceding studies; 2) continue work directed at the application of Lewis acid catalyzed asymmetric [2+2] cycloaddition reactions to (+)-Laurencin (2) and Laurenyne (3) which employs a novel retro-Claisen rearrangement to create the required oxocene ring system in enantiomerically pure form; 3) continue preliminary studies begun recently directed toward the preparation of the novel squalene synthetase inhibitor (+)-Zaragozic Acid C, one of a group of novel antifungal enzyme inhibitors known as the squalestatins 1-3 and the Zaracozic Acids A-C isolated by Glaxo and Merck groups. The approach utilizes a novel application of a net [4-3] cycloaddition to construct the core of the novel squalene synthetase inhibitor Zaragozic Acid C (4); and, 4) initiate synthetic studies directed toward UCT4B (6), a recently characterized DNA gyrase inhibitor, which holds promise as both an antibiotic and a potentially antitumor agent. UCT4B (6) is a member of a small but growing group of biologically active diterpene derivatives which also includes Clerocidin and Terpenticin. A novel protection scheme employing a chiral diol acetal is envisioned to permit control over the key asymmetric centers present in the acyclic chain and provide convenient access to an immediate precursor of the sensitive alpha-ketoaldehyde unit.
在这项资助下进行的研究分为四个主要范畴:

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT K BOECKMAN其他文献

ROBERT K BOECKMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT K BOECKMAN', 18)}}的其他基金

Development of novel bone-targeted chloroquine conjugates to prevent bone resorption.
开发新型骨靶向氯喹结合物以防止骨吸收。
  • 批准号:
    9355087
  • 财政年份:
    2016
  • 资助金额:
    $ 19.12万
  • 项目类别:
Study of osteoblast regulation in TNF-mediated bone loss
TNF介导的骨丢失中成骨细胞调节的研究
  • 批准号:
    8891736
  • 财政年份:
    2013
  • 资助金额:
    $ 19.12万
  • 项目类别:
300 MHZ NMR SPECTROMETER
300 MHz 核磁共振波谱仪
  • 批准号:
    3520029
  • 财政年份:
    1988
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    2175770
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    3278043
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    3278052
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF MEDIUM RING ANTITUMOR SUBSTANCES
中环抗肿瘤物质的合成
  • 批准号:
    3278050
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    6342785
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    3278051
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:
SYNTHESIS OF NOVEL BIOLOGICALLY ACTIVE NATURAL PRODUCTS
新型生物活性天然产物的合成
  • 批准号:
    3278053
  • 财政年份:
    1982
  • 资助金额:
    $ 19.12万
  • 项目类别:

相似海外基金

Biosynthesis of peptidyl nucleoside antifungal antibiotics
肽基核苷抗真菌抗生素的生物合成
  • 批准号:
    8944844
  • 财政年份:
    2015
  • 资助金额:
    $ 19.12万
  • 项目类别:
Screening for new antifungal antibiotics of microbial origin using silkworm infection model with Candida albicans
利用家蚕白色念珠菌感染模型筛选新型微生物源抗真菌抗生素
  • 批准号:
    25460130
  • 财政年份:
    2013
  • 资助金额:
    $ 19.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Synthesis and Biological Evaluation of Antifungal Antibiotics, Spirofungin A and B
抗真菌抗生素螺芬净 A 和 B 的合成及生物学评价
  • 批准号:
    16590026
  • 财政年份:
    2004
  • 资助金额:
    $ 19.12万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of Action of Antifungal Antibiotics
抗真菌抗生素的作用机制
  • 批准号:
    67B5728
  • 财政年份:
    1967
  • 资助金额:
    $ 19.12万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了